Who founded Vico Therapeutics?

Vico Therapeutics was founded by Luc Dochez, Josh Mandel-Brehm.

Who are Vico Therapeutics's investors?

Vico Therapeutics's investors include Droia Ventures, Kurma Partners, Pureos Bioventures, EQT Life Sciences, Seroba Life Sciences, Eurazeo, Idinvest Partners, Polaris Partners.

Vico Therapeutics

9 known investors

Find your way into Vico Therapeutics

265 people in our graph share verified history with the Vico Therapeutics team — schools, employers, funds. One of them is your warm intro.

Detlev Biniszkiewiczunlockedknows Luc Dochez · together at Montis Biosciences (overlapped)

×2knows the team · via Pharvaris

×3knows the team · via Montis Biosciences

×2knows the team · via Vico Therapeutics

×4knows the team · via Arthur D. Little

Vico Therapeutics develops targeted genetic medicines for neurological disorders, with a focus on antisense oligonucleotide therapies designed to address the underlying genetic causes of diseases like Huntington's disease and spinocerebellar ataxias.

AI & Machine Learning Biotech Deep Tech Healthtech Medical Devices

Founders & leadership

Luc Dochez Chair and FounderManaging Partner at Droia Ventures

Josh Mandel-BrehmCo-FounderExecutive Officer, Director at Camp4 Therapeutics Corp

Investors · 9

Droia Ventures✓ confirmed by Vico TherapeuticsLuxembourg · $540K

How we know: Droia Ventures's portfolio page · the company's own site · prnewswire.com · the VCSheet dataset · Not right? Tell us

Kurma Partners✓ confirmed by Vico TherapeuticsParis · $162K – $10.8M

How we know: Kurma Partners's portfolio page · the company's own site · a partner's Signal profile · funding news · prnewswire.com · the VCSheet dataset · Not right? Tell us

Pureos Bioventures✓ confirmed by Vico TherapeuticsPfäffikon

How we know: Pureos Bioventures's portfolio page · the company's own site · funding news · prnewswire.com · Not right? Tell us

EQT Life Sciences✓ confirmed by Vico TherapeuticsLuxembourg · $11M – $66M

How we know: the company's own site · prnewswire.com · Not right? Tell us

Seroba Life Scienceslisted by Seroba Life SciencesDublin · $540K – $7.6M

How we know: funding news · Not right? Tell us

EurazeoreportedParis

How we know: prnewswire.com · Not right? Tell us

Idinvest Partnersreported

How we know: funding news · Not right? Tell us

Polaris PartnersreportedBoston · $500K – $5M

How we know: a partner's Signal profile · Not right? Tell us

Also in the syndicate · 1

Ackermans & van Haarenlead

Funding

SEC filings, press & company announcements

Undisclosed amountSeries BJun 2024
Source ↗
Undisclosed amountSeries BJan 2024
Ackermans & van Haaren (lead), Droia Ventures (lead), EQT Life Sciences (lead), Kurma Partners (lead), Eurazeo, Polaris Partners, Pureos Bioventures
Source ↗
Undisclosed amountSeries AJul 2020
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Vico Therapeutics Announces $60 million (€54 million) Series B Financing to Advance VO659 Clinical-Stage Program for Rare Neurological Diseases and Expand Pipelineprnewswire.com · Jan 2024

Biotech VICO Therapeutics raises $31 million (€27 million) in Series A financing round to advance therapies for rare central nervous system diseases – Vico Therapeuticsvicotx.com · Jul 2020

Frequently asked questions

What does Vico Therapeutics do?: Vico Therapeutics develops targeted genetic medicines for neurological disorders, with a focus on antisense oligonucleotide therapies designed to address the underlying genetic causes of diseases like Huntington's disease and spinocerebellar ataxias.
Who founded Vico Therapeutics?: Vico Therapeutics was founded by Luc Dochez, Josh Mandel-Brehm.
Who are Vico Therapeutics's investors?: Vico Therapeutics's investors include Droia Ventures, Kurma Partners, Pureos Bioventures, EQT Life Sciences, Seroba Life Sciences, Eurazeo, Idinvest Partners, Polaris Partners.